                               SEQUENCE LISTING

<110> APPLIED BIOLOGICAL LABORATORIES, INC.
 
<120> GLYCYRRHIZIN FOR THE TREATMENT OR PROPHYLAXIS OF VIRAL INFECTION

<130> 168778-010702/PCT

<140> PCT/US2021/048945
<141> 2021-09-02

<150> 63/073,859
<151> 2020-09-02

<160> 11    

<170> PatentIn version 3.5

<210> 1
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
tggggyttta crggtaacct                                                   20


<210> 2
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
aacrcgctta acaaagcact c                                                 21


<210> 3
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      probe

<400> 3
tagttgtgat gcwatcatga ctag                                              24


<210> 4
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> Met, Val, Ala, Phe, Tyr, Trp, Lys, Gly, or Arg

<400> 4
Gln Cys Leu Xaa Tyr Lys Lys Pro Glu Cys Gln Ser Asp 
1               5                   10              


<210> 5
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Met, Val, Ala, Phe, Tyr, Trp, Lys, Gly, Leu, or Arg

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Met, Val, Ala, Phe, Tyr, Trp, Lys, Gly, or Arg

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Met, Val, Ala, Phe, Tyr, Trp, Lys, Gly, Leu, or Arg

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Met, Val, Ala, Phe, Tyr, Trp, Lys, Gly, or Arg

<400> 5
Gln Cys Xaa Xaa Xaa Asn Pro Pro Asn Phe Cys Glu Xaa Asp 
1               5                   10                  


<210> 6
<211> 108
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 6
Ser Gly Lys Ser Phe Lys Ala Gly Val Cys Pro Pro Lys Lys Ser Ala 
1               5                   10                  15      


Gln Cys Leu Arg Tyr Lys Lys Pro Glu Cys Gln Ser Asp Trp Gln Cys 
            20                  25                  30          


Pro Gly Lys Lys Arg Cys Cys Pro Asp Thr Cys Gly Ile Lys Cys Leu 
        35                  40                  45              


Asp Pro Val Asp Thr Pro Asn Pro Thr Arg Arg Lys Pro Gly Lys Cys 
    50                  55                  60                  


Pro Val Thr Tyr Gly Gly Asn Cys Leu Met Leu Asn Pro Pro Asn Phe 
65                  70                  75                  80  


Cys Glu Met Asp Gly Gln Cys Lys Arg Asp Leu Lys Cys Cys Met Gly 
                85                  90                  95      


Met Cys Gly Lys Ser Cys Val Ser Pro Val Lys Ala 
            100                 105             


<210> 7
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Ser, Ala, or a substituted amino acid residue

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Met, Val, Ala, Phe, Tyr, Trp, Lys, Gly, or Arg

<220>
<221> MOD_RES
<222> (72)..(72)
<223> Met, Val, Ala, Phe, Tyr, Trp, Lys, Gly, Leu, or Arg

<220>
<221> MOD_RES
<222> (73)..(73)
<223> Met, Val, Ala, Phe, Tyr, Trp, Lys, Gly, or Arg

<220>
<221> MOD_RES
<222> (74)..(74)
<223> Met, Val, Ala, Phe, Tyr, Trp, Lys, Gly, Leu, or Arg

<220>
<221> MOD_RES
<222> (82)..(82)
<223> Met, Val, Ala, Phe, Tyr, Trp, Lys, Gly, or Arg

<220>
<221> MOD_RES
<222> (94)..(94)
<223> Met, Val, Ala, Phe, Tyr, Trp, Lys, Gly, or Arg

<220>
<221> MOD_RES
<222> (96)..(96)
<223> Met, Val, Ala, Phe, Tyr, Trp, Lys, Gly, or Arg

<220>
<221> MOD_RES
<222> (107)..(107)
<223> Ser, Ala, or a substituted amino acid residue

<400> 7
Xaa Gly Lys Ser Phe Lys Ala Gly Val Cys Pro Pro Lys Lys Ser Ala 
1               5                   10                  15      


Gln Cys Leu Xaa Tyr Lys Lys Pro Glu Cys Gln Ser Asp Trp Gln Cys 
            20                  25                  30          


Pro Gly Lys Lys Arg Cys Cys Pro Asp Thr Cys Gly Ile Lys Cys Leu 
        35                  40                  45              


Asp Pro Val Asp Thr Pro Asn Pro Thr Arg Arg Lys Pro Gly Lys Cys 
    50                  55                  60                  


Pro Val Thr Tyr Gly Gln Cys Xaa Xaa Xaa Asn Pro Pro Asn Phe Cys 
65                  70                  75                  80  


Glu Xaa Asp Gly Gln Cys Lys Arg Asp Leu Lys Cys Cys Xaa Gly Xaa 
                85                  90                  95      


Cys Gly Lys Ser Cys Val Ser Pro Val Lys Xaa 
            100                 105         


<210> 8
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      probe

<400> 8
tagttgtgat gcwatcatga ctag                                              24


<210> 9
<211> 15
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      probe

<400> 9
acctgactcc cgtgc                                                        15


<210> 10
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 10
aagctcccaa atggtgttac t                                                 21


<210> 11
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 11
aggattccga gattgaggtt tg                                                22


